India and the United States have commenced trade negotiations in Delhi, focusing on finalizing an interim trade agreement that encompasses various sectors, including healthcare and artificial intelligence.
The discussions, running from June 1 to June 4, aim to address market access, non-tariff measures, and customs facilitation. US Ambassador to India, Sergio Gor, indicated that the negotiations are nearing completion, with a US delegation expected to finalize the remaining details. The bilateral trade has seen a remarkable increase from $20 billion to $220 billion over the past twenty years, highlighting the growing economic ties between the two nations.
Union Commerce Minister Piyush Goyal's recent visit to the US emphasized the intention to enhance collaboration in sectors such as healthcare, manufacturing, and digital payments. The US delegation, led by chief negotiator Brendan Lynch, and India's negotiator Darpan Jain are tasked with navigating this critical trade landscape.
Gor noted that India's economic growth and infrastructure needs align well with US expertise, particularly in emerging technologies and advanced manufacturing. The countries have also established a framework for cooperation in critical minerals, addressing concerns over China's export controls. Additionally, Gor highlighted India's vital role in the US pharmaceutical supply chain, with approximately 40% of generics imported from India, underscoring the trust placed in Indian manufacturing capabilities.
This trade dialogue signifies a pivotal moment for both nations, as they explore opportunities to strengthen their economic relationship while addressing global supply chain resilience and innovation in critical sectors.